DEUTSCHE BETEILIGUNGS AG (DBAN.DE) Stock Fundamental Analysis

FRA:DBAN • DE000A1TNUT7

25.1 EUR
+0.2 (+0.8%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

Taking everything into account, DBAN scores 3 out of 10 in our fundamental rating. DBAN was compared to 117 industry peers in the Capital Markets industry. DBAN has a medium profitability rating, but doesn't score so well on its financial health evaluation. DBAN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • DBAN had positive earnings in the past year.
  • In the past year DBAN had a positive cash flow from operations.
  • In multiple years DBAN reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DBAN reported negative operating cash flow in multiple years.
DBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFDBAN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of DBAN (3.38%) is better than 65.22% of its industry peers.
  • DBAN has a Return On Equity (4.81%) which is in line with its industry peers.
  • The Return On Invested Capital of DBAN (2.53%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROIC 2.53%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
DBAN.DE Yearly ROA, ROE, ROICDBAN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • With a decent Profit Margin value of 31.10%, DBAN is doing good in the industry, outperforming 78.26% of the companies in the same industry.
  • In the last couple of years the Profit Margin of DBAN has declined.
  • DBAN has a better Operating Margin (32.22%) than 72.17% of its industry peers.
  • In the last couple of years the Operating Margin of DBAN has declined.
  • DBAN's Gross Margin of 89.98% is amongst the best of the industry. DBAN outperforms 89.57% of its industry peers.
  • DBAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
DBAN.DE Yearly Profit, Operating, Gross MarginsDBAN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

3

2. Health

2.1 Basic Checks

  • DBAN has less shares outstanding than it did 1 year ago.
  • DBAN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DBAN is higher compared to a year ago.
DBAN.DE Yearly Shares OutstandingDBAN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DBAN.DE Yearly Total Debt VS Total AssetsDBAN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • DBAN has an Altman-Z score of 1.79. This is a bad value and indicates that DBAN is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.79, DBAN is doing good in the industry, outperforming 67.83% of the companies in the same industry.
  • DBAN has a debt to FCF ratio of 93.97. This is a negative value and a sign of low solvency as DBAN would need 93.97 years to pay back of all of its debts.
  • DBAN has a Debt to FCF ratio of 93.97. This is in the better half of the industry: DBAN outperforms 66.09% of its industry peers.
  • DBAN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.31, DBAN is in the better half of the industry, outperforming 68.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Altman-Z 1.79
ROIC/WACCN/A
WACCN/A
DBAN.DE Yearly LT Debt VS Equity VS FCFDBAN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • DBAN has a Current Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DBAN has a Current ratio (0.84) which is in line with its industry peers.
  • DBAN has a Quick Ratio of 0.84. This is a bad value and indicates that DBAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of DBAN (0.84) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.84
DBAN.DE Yearly Current Assets VS Current LiabilitesDBAN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. Growth

3.1 Past

  • DBAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.70%.
  • The Earnings Per Share has been decreasing by -3.13% on average over the past years.
  • DBAN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.87%.
  • DBAN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.25% yearly.
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%

3.2 Future

  • DBAN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -22.84% yearly.
  • DBAN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.93% yearly.
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.84%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DBAN.DE Yearly Revenue VS EstimatesDBAN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 50M -50M 100M 150M 200M
DBAN.DE Yearly EPS VS EstimatesDBAN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.19, which indicates a rather expensive current valuation of DBAN.
  • Based on the Price/Earnings ratio, DBAN is valued a bit cheaper than the industry average as 69.57% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, DBAN is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 12.47, the valuation of DBAN can be described as correct.
  • Based on the Price/Forward Earnings ratio, DBAN is valued cheaper than 81.74% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, DBAN is valued rather cheaply.
Industry RankSector Rank
PE 17.19
Fwd PE 12.47
DBAN.DE Price Earnings VS Forward Price EarningsDBAN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • DBAN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DBAN is cheaper than 62.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 229.51
EV/EBITDA N/A
DBAN.DE Per share dataDBAN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • DBAN's earnings are expected to decrease with -15.27% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%

5

5. Dividend

5.1 Amount

  • DBAN has a Yearly Dividend Yield of 4.02%, which is a nice return.
  • Compared to an average industry Dividend Yield of 3.08, DBAN pays a bit more dividend than its industry peers.
  • DBAN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.02%

5.2 History

  • The dividend of DBAN decreases each year by -5.78%.
Dividend Growth(5Y)-5.78%
Div Incr Years1
Div Non Decr Years2
DBAN.DE Yearly Dividends per shareDBAN.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • DBAN pays out 73.85% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of DBAN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP73.85%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
DBAN.DE Yearly Income VS Free CF VS DividendDBAN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
DBAN.DE Dividend Payout.DBAN.DE Dividend Payout, showing the Payout Ratio.DBAN.DE Dividend Payout.PayoutRetained Earnings

DEUTSCHE BETEILIGUNGS AG

FRA:DBAN (2/27/2026, 7:00:00 PM)

25.1

+0.2 (+0.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06
Earnings (Next)03-10
Inst Owners11.66%
Inst Owner ChangeN/A
Ins Owners38.61%
Ins Owner ChangeN/A
Market Cap471.88M
Revenue(TTM)96.86M
Net Income(TTM)30.13M
Analysts86.15
Price Target36.81 (46.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.02%
Yearly Dividend1.01
Dividend Growth(5Y)-5.78%
DP73.85%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.03%
PT rev (3m)-6.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-6.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.19
Fwd PE 12.47
P/S 4.87
P/FCF 229.51
P/OCF 178.41
P/B 0.75
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)1.46
EY5.82%
EPS(NY)2.01
Fwd EY8.02%
FCF(TTM)0.11
FCFY0.44%
OCF(TTM)0.14
OCFY0.56%
SpS5.15
BVpS33.3
TBVpS30.72
PEG (NY)N/A
PEG (5Y)N/A
Graham Number33.08
Profitability
Industry RankSector Rank
ROA 3.38%
ROE 4.81%
ROCE 3.86%
ROIC 2.53%
ROICexc 2.68%
ROICexgc 2.85%
OM 32.22%
PM (TTM) 31.1%
GM 89.98%
FCFM 2.12%
ROA(3y)1.68%
ROA(5y)5.34%
ROE(3y)1.96%
ROE(5y)5.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-35.11%
ROICexgc growth 5Y-7.26%
ROICexc growth 3Y-36.76%
ROICexc growth 5Y-8.68%
OM growth 3Y-18.51%
OM growth 5Y-4.58%
PM growth 3Y-19.55%
PM growth 5Y-6.09%
GM growth 3Y-1.43%
GM growth 5Y-0.83%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 93.97
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 6.82%
Current Ratio 0.84
Quick Ratio 0.84
Altman-Z 1.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.91%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.7%
EPS 3Y-38.96%
EPS 5Y-3.13%
EPS Q2Q%-99.1%
EPS Next Y-71.64%
EPS Next 2Y-36.25%
EPS Next 3Y-15.27%
EPS Next 5Y-22.84%
Revenue 1Y (TTM)-10.87%
Revenue growth 3Y-21%
Revenue growth 5Y7.25%
Sales Q2Q%-61.51%
Revenue Next Year-22.08%
Revenue Next 2Y-16.59%
Revenue Next 3Y-7.69%
Revenue Next 5Y-6.93%
EBIT growth 1Y-37.36%
EBIT growth 3Y-35.63%
EBIT growth 5Y2.34%
EBIT Next Year-64.73%
EBIT Next 3Y-9.54%
EBIT Next 5Y-15.44%
FCF growth 1Y109.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.05%
OCF growth 3YN/A
OCF growth 5YN/A

DEUTSCHE BETEILIGUNGS AG / DBAN.DE FAQ

What is the ChartMill fundamental rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to DBAN.DE.


What is the valuation status of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to DEUTSCHE BETEILIGUNGS AG (DBAN.DE). This can be considered as Fairly Valued.


What is the profitability of DBAN stock?

DEUTSCHE BETEILIGUNGS AG (DBAN.DE) has a profitability rating of 4 / 10.


What is the financial health of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) stock?

The financial health rating of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is 3 / 10.


What is the earnings growth outlook for DEUTSCHE BETEILIGUNGS AG?

The Earnings per Share (EPS) of DEUTSCHE BETEILIGUNGS AG (DBAN.DE) is expected to decline by -71.64% in the next year.